【調査レポート】肺炎球菌ワクチンの世界市場分析・規模・シェア・成長・動向・予測：製品別（Synflorix、Prevenar-13、PCV 13、V114、PCV-20、PCV-10、PPSV-23）、流通経路別（卸売業者（薬局チャネル）、専門会社、公共機関）、部門別（パブリック、プライベート）

• 英文タイトル：Pneumococcal Vaccines Market (Product - Synflorix, Prevenar-13, PCV 13, V114, PCV-20, PCV-10, PPSV-23; Distribution Channel - Wholesalers (pharmacy channel), Specialized Companies, Public Authorities; Sector - Public, Private) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Transparency Market Researchが調査・発行した産業分析レポートです。肺炎球菌ワクチンの世界市場分析・規模・シェア・成長・動向・予測：製品別（Synflorix、Prevenar-13、PCV 13、V114、PCV-20、PCV-10、PPSV-23）、流通経路別（卸売業者（薬局チャネル）、専門会社、公共機関）、部門別（パブリック、プライベート） / Pneumococcal Vaccines Market (Product - Synflorix, Prevenar-13, PCV 13, V114, PCV-20, PCV-10, PPSV-23; Distribution Channel - Wholesalers (pharmacy channel), Specialized Companies, Public Authorities; Sector - Public, Private) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 / TPM-C02102資料のイメージです。

• レポートコード：TPM-C02102
• 出版社/出版日：Transparency Market Research / 2018年10月26日
• レポート形態：英文、PDF、285ページ
• 納品方法：Eメール
• 産業分類：Pharmaceutical

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Global Site License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本資料は、肺炎球菌ワクチンの世界市場について調べ、肺炎球菌ワクチンの世界規模、市場動向、市場環境、製品別（Synflorix、Prevenar-13、PCV 13、V114、PCV-20、PCV-10、PPSV-23）分析、流通経路別（卸売業者（薬局チャネル）、専門会社、公共機関）分析、部門別（パブリック、プライベート）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・肺炎球菌ワクチンの世界市場動向
・肺炎球菌ワクチンの世界市場環境
・肺炎球菌ワクチンの世界市場規模
・肺炎球菌ワクチンの世界市場規模：製品別（Synflorix、Prevenar-13、PCV 13、V114、PCV-20、PCV-10、PPSV-23）
・肺炎球菌ワクチンの世界市場規模：流通経路別（卸売業者（薬局チャネル）、専門会社、公共機関）
・肺炎球菌ワクチンの世界市場規模：部門別（パブリック、プライベート）
・肺炎球菌ワクチンの世界市場：地域別市場規模・分析
・肺炎球菌ワクチンの北米市場規模・予測
・肺炎球菌ワクチンのアメリカ市場規模・予測
・肺炎球菌ワクチンのヨーロッパ市場規模・予測
・肺炎球菌ワクチンのアジア市場規模・予測
・肺炎球菌ワクチンの日本市場規模・予測
・肺炎球菌ワクチンの中国市場規模・予測
・肺炎球菌ワクチンのインド市場規模・予測
・競争状況・関連企業情報

Global Pneumococcal Vaccines Market: Overview

This report analyzes the current and future scenario of the global pneumococcal vaccines market. Increase in patient population, growth of the pharmaceutical industry, rise in government investments for vaccination programs, improvement in health care infrastructure, and surge in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

The global pneumococcal vaccines market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, distribution channel, sector, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global pneumococcal vaccines market.

Global Pneumococcal Vaccines Market: Key Segments

Based on product type, the global pneumococcal vaccines market has been segmented into Synflorix, Prevenar-13, PCV 13 (pipeline), V114 (Merck), PCV-20 (Pfizer), PCV-10 (SII), and PPSV- 23. Each of these segments is categorized into pediatric and adults. In terms of distribution channel, the global market has been classified into wholesalers (pharmacy channel), specialized companies, public authorities, and others. Based on sector, the market has been bifurcated into private and public. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Pneumococcal Vaccines Market: Regional Outlook

In terms of region, the global pneumococcal vaccines market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, Belgium, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of the World (Middle East and Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global pneumococcal vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Pfizer, Inc., Merck & Co., Inc., SK Chemicals, Serum Institute of India Pvt. Ltd., Chengdu Institute of Biological Products Co., Ltd., GlaxoSmithKline plc, Sanofi, and Walvax Biotechnology Co., Ltd.

The global pneumococcal vaccines market has been segmented as below:

Global Pneumococcal Vaccines Market, by Product Type
Synflorix
Pediatric
Adult
Prevenar-13
Pediatric
Adult
PCV 13 (pipeline)
Pediatric
Adult
V114 (Merck)
Pediatric
Adult
PCV-20 (Pfizer)
Pediatric
Adult
PCV-10 (SII)
Pediatric
Adult
PPSV- 23
Pediatric
Adult
Global Pneumococcal Vaccines Market, by Distribution Channel
Wholesalers (pharmacy channel)
Specialized Companies
Public Authorities
Others
Global Pneumococcal Vaccines Market, by Sector
Public
Private
Global Pneumococcal Vaccines Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Belgium
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Rest of the World
Middle East
Africa

レポート目次

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary
3.1. Global Pneumococcal Vaccines Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
3.2. Global Pneumococcal Vaccines Market: Market Snapshot, 2016

4. Market Overview
4.1. Overview
4.2. Global Pneumococcal Vaccines Market Size (US$ Mn) Forecast, 2016–2026
4.3. Global Pneumococcal Vaccines Market Outlook
4.4. Approved & Pipeline Products Snapshot

5. Market Dynamics
5.1. Drivers
5.1.1. Government participation in design & implementation of comprehensive vaccination programs
5.1.2. Increase in investments by public & private players in R&D of conjugate pneumococcal vaccines
5.2. Restraints
5.2.1. Longer timeline and high cost associated with development of pneumococcal vaccines
5.3. Opportunities
5.3.1. Development of multivalent conjugated vaccines with different serotypes
5.4. Trends
5.4.1. Public-Private Partnerships

6. Global Pneumococcal Vaccines Market Analysis, by Product Type
6.1. Introduction
6.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Product Type
6.3. Pneumococcal Vaccines Market Analysis, by Product Type
6.3.1. Synflorix
6.3.1.1. Pediatric
6.3.1.2. Adult
6.3.2. Prevenar-13
6.3.2.1. Pediatric
6.3.2.2. Adult
6.3.3. PCV 13 (pipeline)
6.3.3.1. Pediatric
6.3.3.2. Adult
6.3.4. V114 (Merck)
6.3.4.1. Pediatric
6.3.4.2. Adult
6.3.5. PCV-20 (Pfizer)
6.3.5.1. Pediatric
6.3.5.2. Adult
6.3.6. PCV-10 (SII)
6.3.6.1. Pediatric
6.3.6.2. Adult
6.3.7. PPSV- 23
6.3.7.1. Pediatric
6.3.7.2. Adult

7. Global Pneumococcal Vaccines Market Analysis, by Distribution Channel
7.1. Introduction
7.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
7.3. Pneumococcal Vaccines Market Analysis, by Distribution Channel
7.3.1. Wholesalers
7.3.2. Specialized Companies
7.3.3. Public Authorities
7.3.4. Others

8. Global Pneumococcal Vaccines Market Analysis, by Sector
8.1. Introduction
8.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Sector
8.3. Pneumococcal Vaccines Market Analysis, by Sector
8.3.1. Public
8.3.2. Private

9. U.S. Pneumococcal Vaccines Market Analysis
9.1. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
9.2. U.S. Pneumococcal Vaccines Market Forecast, by Product Type
9.2.1. Prevanar-13
9.2.2. V114
9.2.3. PCV-20
9.2.4. Pneumovax-23
9.3. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
9.4. U.S. Pneumococcal Vaccines Market Forecast, by Distribution Channel
9.4.1. Wholesalers
9.4.2. Specialized Companies
9.4.3. Public Authorities
9.4.4. Others
9.5. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Sector
9.6. U.S. Pneumococcal Vaccines Market Forecast, by Sector
9.6.1. Private
9.6.2. Public
10. Canada Pneumococcal Vaccines Market Analysis

10.1. Canada Pneumococcal Vaccines Market Value Share Analysis, by Product Type
10.2. Canada Pneumococcal Vaccines Market Forecast, by Product Type
10.2.1. Prevenar-13
10.2.2. Synflorix
10.2.3. V-114
10.2.4. Pneumo – 23
10.2.5. Pnuemovax-23
10.3. Canada Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
10.4. Canada Pneumococcal Vaccines Market Forecast, by Distribution Channel
10.4.1. Wholesalers
10.4.2. Specialized Companies
10.4.3. Public Authorities
10.4.4. Others
10.5. Canada Pneumococcal Vaccines Market Value Share Analysis, by Sector
10.6. Canada Pneumococcal Vaccines Market Forecast, by Sector
10.6.1. Private
10.6.2. Public

11. Germany Pneumococcal Vaccines Market Analysis
11.1. Germany Pneumococcal Vaccines Market Value Share Analysis, by Product Type
11.2. Germany Pneumococcal Vaccines Market Forecast, by Product Type
11.2.1. Prevenar-13
11.2.2. Synflorix
11.2.3. V-114
11.2.4. PCV-20
11.2.5. Pnuemovax-23
11.3. Germany Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
11.4. Germany Pneumococcal Vaccines Market Forecast, by Distribution Channel
11.4.1. Wholesalers
11.4.2. Specialized Companies
11.4.3. Public Authorities
11.4.4. Others
11.5. Germany Pneumococcal Vaccines Market Value Share Analysis, by Sector
11.6. Germany Pneumococcal Vaccines Market Forecast, by Sector
11.6.1. Private
11.6.2. Public

12. U.K. Pneumococcal Vaccines Market Analysis
12.1. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
12.2. U.K. Pneumococcal Vaccines Market Forecast, by Product Type
12.2.1. Prevenar-13
12.2.2. Synflorix
12.2.3. V-114
12.2.4. PCV-20
12.2.5. Pnuemovax-23
12.3. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
12.4. U.K. Pneumococcal Vaccines Market Forecast, by Distribution Channel
12.4.1. Wholesalers
12.4.2. Specialized Companies
12.4.3. Public Authorities
12.4.4. Others
12.5. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Sector
12.6. U.K. Pneumococcal Vaccines Market Forecast, by Sector
12.6.1. Private
12.6.2. Public

13. France Pneumococcal Vaccines Market Analysis
13.1. France Pneumococcal Vaccines Market Value Share Analysis, by Product Type
13.2. France Pneumococcal Vaccines Market Forecast, by Product Type
13.2.1. Prevenar-13
13.2.2. Synflorix
13.2.3. V-114
13.2.4. PCV-20
13.2.5. Pnuemovax-23
13.3. France Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
13.4. France Pneumococcal Vaccines Market Forecast, by Distribution Channel
13.4.1. Wholesalers
13.4.2. Specialized Companies
13.4.3. Public Authorities
13.4.4. Others
13.5. France Pneumococcal Vaccines Market Value Share Analysis, by Sector
13.6. France Pneumococcal Vaccines Market Forecast, by Sector
13.6.1. Private
13.6.2. Public

14. Italy Pneumococcal Vaccines Market Analysis
14.1. Italy Pneumococcal Vaccines Market Value Share Analysis, by Product Type
14.2. Italy Pneumococcal Vaccines Market Forecast, by Product Type
14.2.1. Prevenar-13
14.2.2. Synflorix
14.2.3. V-114
14.2.4. PCV-20
14.2.5. Pnuemovax-23
14.3. Italy Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
14.4. Italy Pneumococcal Vaccines Market Forecast, by Distribution Channel
14.4.1. Wholesalers
14.4.2. Specialized Companies
14.4.3. Public Authorities
14.4.4. Others
14.5. Italy Pneumococcal Vaccines Market Value Share Analysis, by Sector
14.6. Italy Pneumococcal Vaccines Market Forecast, by Sector
14.6.1. Private
14.6.2. Public

15. Spain Pneumococcal Vaccines Market Analysis
15.1. Spain Pneumococcal Vaccines Market Value Share Analysis, by Product Type
15.2. Spain Pneumococcal Vaccines Market Forecast, by Product Type
15.2.1. Prevenar-13
15.2.2. Synflorix
15.2.3. V-114
15.2.4. PCV-20
15.2.5. Pnuemovax-23
15.3. Spain Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
15.4. Spain Pneumococcal Vaccines Market Forecast, by Distribution Channel
15.4.1. Wholesalers
15.4.2. Specialized Companies
15.4.3. Public Authorities
15.4.4. Others
15.5. Spain Pneumococcal Vaccines Market Value Share Analysis, by Sector
15.6. Spain Pneumococcal Vaccines Market Forecast, by Sector
15.6.1. Private
15.6.2. Public

16. Belgium Pneumococcal Vaccines Market Analysis
16.1. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Product Type
16.2. Belgium Pneumococcal Vaccines Market Forecast, by Product Type
16.2.1. Prevenar-13
16.2.2. Synflorix
16.2.3. V-114
16.2.4. PCV-20
16.2.5. Pnuemovax-23
16.3. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
16.4. Belgium Pneumococcal Vaccines Market Forecast, by Distribution Channel
16.4.1. Wholesalers
16.4.2. Specialized Companies
16.4.3. Public Authorities
16.4.4. Others
16.5. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Sector
16.6. Belgium Pneumococcal Vaccines Market Forecast, by Sector
16.6.1. Private
16.6.2. Public

17. India Pneumococcal Vaccines Market Analysis
17.1. India Pneumococcal Vaccines Market Value Share Analysis, by Product Type
17.2. India Pneumococcal Vaccines Market Forecast, by Product Type
17.2.1. Prevenar-13
17.2.2. Synflorix
17.2.3. SIIL PCV-10
17.2.4. PCV-20
17.2.5. Pnuemovax-23
17.3. India Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
17.4. India Pneumococcal Vaccines Market Forecast, by Distribution Channel
17.4.1. Wholesalers
17.4.2. Specialized Companies
17.4.3. Public Authorities
17.4.4. Others
17.5. India Pneumococcal Vaccines Market Value Share Analysis, by Sector
17.6. India Pneumococcal Vaccines Market Forecast, by Sector
17.6.1. Private
17.6.2. Public
18. China Pneumococcal Vaccines Market Analysis
18.1. China Pneumococcal Vaccines Market Value Share Analysis, by Product Type
18.2. China Pneumococcal Vaccines Market Forecast, by Product Type
18.2.1. Prevenar-13
18.2.2. PCV 13 (pipeline)
18.2.3. PPSV 23
18.3. China Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
18.4. China Pneumococcal Vaccines Market Forecast, by Distribution Channel
18.4.1. Wholesalers
18.4.2. Specialized Companies
18.4.3. Public Authorities
18.4.4. Others
18.5. China Pneumococcal Vaccines Market Value Share Analysis, by Sector
18.6. China Pneumococcal Vaccines Market Forecast, by Sector
18.6.1. Private
18.6.2. Public

19. Japan Pneumococcal Vaccines Market Analysis
19.1. Japan Pneumococcal Vaccines Market Value Share Analysis, by Product Type
19.2. Japan Pneumococcal Vaccines Market Forecast, by Product Type
19.2.1. Prevenar-13
19.2.2. Synflorix
19.2.3. PPSV 23
19.3. Japan Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
19.4. Japan Pneumococcal Vaccines Market Forecast, by Distribution Channel
19.4.1. Wholesalers
19.4.2. Specialized Companies
19.4.3. Public Authorities
19.4.4. Others
19.5. Japan Pneumococcal Vaccines Market Value Share Analysis, by Sector
19.6. Japan Pneumococcal Vaccines Market Forecast, by Sector
19.6.1. Private
19.6.2. Public

20. Australia Pneumococcal Vaccines Market Analysis
20.1. Australia Pneumococcal Vaccines Market Value Share Analysis, by Product Type
20.2. Australia Pneumococcal Vaccines Market Forecast, by Product Type
20.2.1. Prevenar-13
20.2.2. Synflorix
20.2.3. V114
20.2.4. Pnuemovax-23
20.3. Australia Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
20.4. Australia Pneumococcal Vaccines Market Forecast, by Distribution Channel
20.4.1. Wholesalers
20.4.2. Specialized Companies
20.4.3. Public Authorities
20.4.4. Others
20.5. Australia Pneumococcal Vaccines Market Value Share Analysis, by Sector
20.6. Australia Pneumococcal Vaccines Market Forecast, by Sector
20.6.1. Private
20.6.2. Public

21. New Zealand Pneumococcal Vaccines Market Analysis
21.1. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Product Type
21.2. New Zealand Pneumococcal Vaccines Market Forecast, by Product Type
21.2.1. Prevenar-13
21.2.2. Synflorix
21.2.3. Pnuemovax-23
21.3. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
21.4. New Zealand Pneumococcal Vaccines Market Forecast, by Distribution Channel
21.4.1. Wholesalers
21.4.2. Specialized Companies
21.4.3. Public Authorities
21.4.4. Others
21.5. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Sector
21.6. New Zealand Pneumococcal Vaccines Market Forecast, by Sector
21.6.1. Private
21.6.2. Public

22. Brazil Pneumococcal Vaccines Market Analysis
22.1. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Product Type
22.2. Brazil Pneumococcal Vaccines Market Forecast, by Product Type
22.2.1. Prevenar-13
22.2.2. Synflorix
22.2.3. Pnuemovax-23
22.3. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
22.4. Brazil Pneumococcal Vaccines Market Forecast, by Distribution Channel
22.4.1. Wholesalers
22.4.2. Specialized Companies
22.4.3. Public Authorities
22.4.4. Others
22.5. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Sector
22.6. Brazil Pneumococcal Vaccines Market Forecast, by Sector
22.6.1. Private
22.6.2. Public

23. Mexico Pneumococcal Vaccines Market Analysis
23.1. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Product Type
23.2. Mexico Pneumococcal Vaccines Market Forecast, by Product Type
23.2.1. Prevenar-13
23.2.2. Synflorix
23.2.3. Pnuemovax-23
23.3. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
23.4. Mexico Pneumococcal Vaccines Market Forecast, by Distribution Channel
23.4.1. Wholesalers
23.4.2. Specialized Companies
23.4.3. Public Authorities
23.4.4. Others
23.5. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Sector
23.6. Mexico Pneumococcal Vaccines Market Forecast, by Sector
23.6.1. Private
23.6.2. Public

24. Rest of the World Pneumococcal Vaccines Market Analysis
24.1. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Product Type
24.2. Rest of the World Pneumococcal Vaccines Market Forecast, by Product Type
24.2.1. Prevenar-13
24.2.2. Synflorix
24.2.3. V-114
24.2.4. PCV-20
24.2.5. PCV-10 (SII)
24.2.6. Pnuemovax-23
24.3. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
24.4. Rest of the World Pneumococcal Vaccines Market Forecast, by Distribution Channel
24.4.1. Wholesalers
24.4.2. Specialized Companies
24.4.3. Public Authorities
24.4.4. Others
24.5. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Sector
24.6. Rest of the World Pneumococcal Vaccines Market Forecast, by Sector
24.6.1. Private
24.6.2. Public
24.7. Rest of the World Pneumococcal Vaccines Market Forecast, by Region

25. Competition Landscape
25.1. Global Pneumococcal Vaccines Market Share Analysis, by Company (2017)
25.2. Company Profiles
25.2.1. Pfizer, Inc.
25.2.2. Merck & Co., Inc.
25.2.3. SK Chemicals
25.2.4. Serum Institute of India Pvt. Ltd.
25.2.5. Chengdu Institute of Biological Products Co., Ltd.
25.2.6. GlaxoSmithKline plc
25.2.7. Sanofi
25.2.8. Walvax Biotechnology Co., Ltd.

List of Tables

TABLE 1 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 2 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 3 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 4 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 5 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 6 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 7 U.S. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 8 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 9 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 10 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 11 Canada Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 12 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 13 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 14 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 15 Germany Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 16 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 17 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 18 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 19 U.K. Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 20 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 21 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 22 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 23 France Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 24 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 25 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 26 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 27 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 28 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 29 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 30 Spain Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 31 Italy Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 32 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 33 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 34 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 35 Belgium Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 36 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 37 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 38 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 39 India Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 40 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 41 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 42 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 43 China Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 44 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 45 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 46 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 47 Japan Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 48 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 49 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 50 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 51 Australia Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 52 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 53 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 54 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 55 New Zealand Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 56 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 57 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 58 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 59 Brazil Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 60 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 61 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 62 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 63 Mexico Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 64 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 65 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
TABLE 66 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
TABLE 67 Rest of the World (RoW) Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Sector, 2016–2026
TABLE 68 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Region, 2016–2026
TABLE 69 North America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country, 2016–2026
TABLE 70 Europe Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 71 Asia Pacific Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
TABLE 72 Latin America Pneumococcal Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

Pneumococcal Vaccines Market (Product Type– 7- Valent PCV, 10- Valent PCV, 13- Valent PCV, 23- Valent PPSV; Distribution Channel - Hospitals, Clinics, Other Distribution Channels) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026
TPM-B04131 2017年12月 170Pages
本資料は、肺炎球菌ワクチンの世界市場について調べ、肺炎球菌ワクチンの世界規模、市場動向、市場環境、製品別分析、流通経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法

世界の肺炎球菌ワクチン接種市場予測（～2028年）：PPSV 23、PCV 7/13、PCV 10

Global Pneumococcal Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22F19552 2022年11月 92Pages
「Global Pneumococcal Vaccination Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の...

ワセリンの世界市場分析・規模・シェア・成長・動向・予測：ワセリン種類別、原子価別、投与経路別、症状別、流通経路別

Vaccines Market (Vaccine Type - Inactivated, Live Attenuated, Toxoid, Conjugate; Valance - Monovalent, Multivalent; Route of Administration - Oral, Injectable; Indication - Influenza, Hepatitis, Polio, Meningococcal Disease, Pneumococcal Disease, DTP, Rotavirus, MMR, Human Papilloma Virus; Distribution Channel - Institutional Sales, Hospital Pharmacies, Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
TPM-B04219 2018年3月 289Pages
本資料は、ワセリンの世界市場について調べ、ワセリンの世界規模、市場動向、市場環境、ワセリン種類別分析、原子価別分析、投与経路別分析、症状別分析、流通経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
...

施設管理の世界市場分析・規模・シェア・成長・動向・予測：サービスタイプ別（ハードサービス、ソフトサービス）、産業別（企業、政府・公共機関、ヘルスケア、製造、住宅・教育機関、小売・商業、その他）

Facilities Management Market (Service Type - Hard Services, Soft Services; Industry - Corporate, Government and Public Sector, Health Care, Manufacturing, Residential and Education Institutions, Retail and Commercial, and Others (Food, Sport)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
TPM-B05159 2018年4月20日 110Pages
本資料は、施設管理の世界市場について調べ、施設管理の世界規模、市場動向、市場環境、サービスタイプ別（ハードサービス、ソフトサービス）分析、産業別（企業、政府・公共機関、ヘルスケア、製造、住宅・教育機関、小売・商業、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国...

電子セキュリティの世界市場：製品別（アクセス・制御システム、監視・アラートシステム、盗難防止システム、テロ対策・検査装置）、用途別（環境、公共機関、税関執務）、地域別分析

Global Electronic Security Market - Segmented by Product (Access and Control System, Surveillance and Alert System, Anti-theft System, Antiterrorist and Inspection Equipment), Application (Environmental, Public Sector, Custom Service Sector), and Region - Growth, Trends, and Forecast (2018 - 2023)
B-MOR-05180 2018年4月 90Pages
本資料は、電子セキュリティの世界市場について調べ、電子セキュリティの世界規模、市場動向、市場環境、製品別（アクセス・制御システム、監視・アラートシステム、盗難防止システム、テロ対策・検査装置）分析、用途別（環境、公共機関、税関執務）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業...